Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism | BMC Cancer | Full Text

Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism | BMC Cancer | Full Text

Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism

Polymorphisms in MTHFR gene influence risk and overall survival of patients with brain tumor. Global genomic DNA (gDNA) methylation profile from tumor tissues is replicated in peripheral leukocytes. This study ai...

Authors:Giselle M. Faria, Igor D. P. Soares, Marcela D’Alincourt Salazar, Marcia R. Amorim, Bruno L. Pessoa, Clovis O. da Fonseca and Thereza Quirico-Santos

Citation:BMC Cancer 2020 20:294

Content type:Research article

Published on: 7 April 2020

• ViewFull Text
 
• ViewPDF